RETIPHARMA
RetiPharma is a Danish Biotech company that is developing products for treatment of degenerative eye disorders based on peptides that exerts neuroprotective effect in the eye.
RETIPHARMA
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.retipharma.com
Total Employee:
1+
Status:
Active
Contact:
(+45) 30 30 40 83
Total Funding:
1.3 M EUR
Technology used in webpage:
Content Delivery Network Domain Not Resolving Amazon DigiCert SSL CloudFront OpenResty AWS Global Accelerator Encryption Everywhere
Investors List
BioInnovation Institute
BioInnovation Institute investment in Venture Round - RetiPharma
More informations about "RetiPharma"
RetiPharma - Crunchbase Company Profile & Funding
Organization. RetiPharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... RetiPharma is a Danish Biotech company that …See details»
RetiPharma - Funding, Financials, Valuation & Investors
RetiPharma is a Danish Biotech company. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
RetiPharma closes and sends asset back to founders
Nov 1, 2019 RetiPharma was one of the first start-ups in the Creation House program and funded with a convertible loan of DKK 10M by BioInnovation Institute. The loan is now converted into a donation. “The funding has allowed …See details»
Retipharma Ivs - Company Profile and News - Bloomberg Markets
Company profile page for Retipharma Ivs including stock price, company news, executives, board members, and contact informationSee details»
Recipharm - EQT Group
A Specialty Pharma CDMO providing a full-service offering to leading Pharma and Biotech firms. Starting with a single site in Sweden in 1995, Recipharm has transformed into a leading …See details»
RetiPharma to develop treatments of degenerative eye …
Denmark based RetiPharma, focusing on the development of products for the treatment of degenerative eye disorders based on an in vivo platform for translation from in vivo models to humans, is pleased to announce that it has …See details»
Recipharm completes divestment of seven sites
Sep 3, 2024 Recipharm, a leading global contract development and manufacturing organisation, today announced the completion of the divestment of seven sites to Blue Wolf Capital Partners.See details»
Uppsala - Recipharm
Recipharm in Uppsala, Sweden. Recipharm in Uppsala is one of Recipharm’s manufacturing facilities. The site is located in Uppsala, Sweden. The Uppsala facility is dedicated for API …See details»
Similar companies to RetiPharma - VentureRadar
RetiPharma. Export. Neuroscientific Biopharmaceuticals. Publicly Traded. Founded 2016. Australia. Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) …See details»
击败辉瑞（pfizer） 以色列梯瓦制药50亿吞并Ratiopharm_生物探索
3月18日，全球最大的仿制药厂以色列梯瓦制药对外宣布，将以50亿美元的价格收购德国大型仿制药生产企业Ratiopharm公司，此举将使梯瓦进一步巩固其在仿制药行业的龙头地位。 击败辉 …See details»
Arranta Bio, a Recipharm company, signs contract with MIT to …
Apr 28, 2023 Contract with MIT follows the largest award from FDA's Center for Biologics Evaluation and Research office (CBER) to MIT; Potential to support better response to new …See details»
CDMO Recipharm sells 7 facilities in Europe to Blue Wolf Capital
Apr 2, 2024 Blue Wolf will form a new CDMO company with the sites and reveal its name after the deal closes. Peter Kruger, Recipharm’s oral solid dose strategy chief for the last two-plus …See details»
ratiopharm GmbH - Financial Times
Mar 18, 2010 Stay up-to-date with breaking news and top stories on ratiopharm GmbH. In-depth analysis, industry insights and expert opinionSee details»
Teva to buy Ratiopharm for nearly $5 billion | Reuters
Mar 18, 2010 Teva, which beat U.S. drugs powerhouse Pfizer and Iceland's Actavis in the race for Ratiopharm, said the combined company would have had 2009 revenues of $16.2 billion, …See details»
Ratiopharm Group - Encyclopedia.com
Ratiopharm Group Graf-Arco-Strasse 3Ulm, D-89079GermanyTelephone: (49 731) 402-02Fax: (49 731) 402-78 32Web site: https://www.ratiopharm.com Source for information on Ratiopharm …See details»
Pharmaceutical Sustainability Report | Recipharm
Jan 1, 2023 Recipharm sustainability report 2022. Recipharm sustainability report 2021 . Other external reporting. CDP reporting We scored B for Climate and B- for Water in 2023.See details»
Ratiopharm - Crunchbase Company Profile & Funding
May 30, 2017 Ratiopharm is a pharmaceutical brand that offers generic prescription medicines. The company offers products in areas such as allergies, cardiovascular disorders, …See details»
Ratiopharm - Wikipedia
Ratiopharm was founded by Adolf Merckle and makes generic pharmaceuticals. They are based in Ulm, Germany, with products being distributed [clarification needed] in over 35 countries …See details»
ReciBioPharm secures a significant grant to advance RNA …
Jan 13, 2025 Recipharm AB Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.comSee details»
2025 NBA Mock Draft V.5 - No Ceilings
Mar 14, 2025 Jam: Utah lands a potential franchise player and lead guard engine in Dylan Harper to pair with Lauri Markkanen as the pillars of the organization through their rebuild and …See details»